cm 7116 has been researched along with Substance Withdrawal Syndrome in 1 studies
norflutoprazepam: structure
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess pharmacodynamic and pharmacokinetic properties of acute, subchronic and withdrawn quazepam, a single-blind, longitudinal study was run in eight male, healthy young volunteers." | 1.28 | Longitudinal study on pharmacodynamics and pharmacokinetics of acute, steady-state and withdrawn quazepam. ( Kauert, G; Klausnitzer, W; Schaffler, K; Wauschkuhn, CH, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schaffler, K | 1 |
| Kauert, G | 1 |
| Wauschkuhn, CH | 1 |
| Klausnitzer, W | 1 |
1 other study available for cm 7116 and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Longitudinal study on pharmacodynamics and pharmacokinetics of acute, steady-state and withdrawn quazepam.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Electrooculography; Flurazepam; Hemo | 1989 |